Skip to Content Facebook Feature Image

Mississippi executes a man convicted of raping and killing a college student

News

Mississippi executes a man convicted of raping and killing a college student
News

News

Mississippi executes a man convicted of raping and killing a college student

2025-10-16 08:28 Last Updated At:08:40

PARCHMAN, Miss. (AP) — A Mississippi man convicted of kidnapping, raping and killing a 20-year-old community college student in 1993 was executed Wednesday.

Charles Crawford, 59, was pronounced dead at 6:15 p.m. following a lethal injection at the Mississippi State Penitentiary in Parchman.

Crawford had spent more than 30 years on death row. His execution comes several months after the execution of Mississippi’s longest-serving death row inmate in a year of increasing executions nationwide.

Given the chance to make a final statement, Crawford said, “To my family, I love you. I’m at peace. I’ve got God’s peace,” and added, “I’ll be in heaven.”

He also addressed Ray’s family, saying, “To the victim’s family, true closure and true peace, you cannot reach that without God.”

The execution got underway at 6:01 p.m. and Crawford could be seen taking deep breaths. Five minutes later, he was declared unconscious. At 6:08 p.m., his breathing became slower and shallower and his mouth quivered. A minute later, he took a deep breath and then his chest appeared to stop moving.

Crawford was convicted of abducting Kristy Ray from her parents’ home in northern Mississippi’s Tippah County on Jan. 29, 1993. According to court records, when Ray’s mother came home, her daughter’s car was gone and a handwritten ransom note had been left on the table.

Crawford was arrested a day later and said he was returning from a hunting trip. He later told authorities he blacked out and did not recall killing Ray.

At the time of that arrest, Crawford was days away from going to trial on a separate assault charge stemming from an attack in 1991 in which Crawford was accused of raping a 17-year-old girl and hitting her friend with a hammer.

Despite his assertions that he had experienced blackouts and did not remember committing either the rape or the hammer attack, Crawford was found guilty of both charges in two separate trials.

His prior rape conviction was considered an “aggravating circumstance” by jurors in Crawford’s capital murder trial, paving the way for his death sentence.

During a press conference after the execution, Marc McClure, the chief superintendent of operations for the Mississippi Department of Corrections, said the execution went “as well as could be expected” and asked people to keep the victim’s family in their prayers. None of Crawford or Ray’s family members addressed the press.

Over the past three decades, Crawford tried unsuccessfully to overturn his death sentence.

His lawyers had appealed to the U.S. Supreme Court, but in an order issued minutes before the execution was scheduled to take place, the high court declined without explanation to stop it. Justice Sonia Sotomayor wrote a dissent that was joined by Justices Elena Kagan and Ketanji Brown Jackson.

The appeal alleged that Crawford’s lawyers admitted his guilt in the capital murder trial and pursued an insanity defense despite Crawford’s repeated objections.

“It’s almost like he didn’t even get the chance to have innocent or guilty matter because his attorney just overrode his wishes from the outset,” said Krissy Nobile, the director of the Mississippi Office of Capital Post-Conviction Counsel, who represented Crawford.

Sotomayor in her dissent noted that a 2018 ruling by the high court held that lawyers cannot override a defendant’s explicit and unequivocal decision not to admit guilt at trial. Under that decision, Crawford could have proven that his Sixth Amendment rights were violated and would likely be entitled to a new trial, she wrote.

But Crawford’s convictions became final before that case was decided, and the court “has not squarely resolved” whether the 2018 ruling is retroactive and applies in postconviction proceedings, Sotomayor wrote.

“The Court refuses to resolve that question, even though a man’s life is in the balance,” she wrote.

The Mississippi Supreme Court had dismissed the argument in September, writing that Crawford should have brought the appeal sooner and did not present adequate reasoning why the Supreme Court ruling should be retroactive.

In a statement released after the execution, the Mississippi Office of Capital Post-Conviction Counsel said he was executed without receiving a fair trial.

“Despite a legal system that failed him, Charles Crawford (“Chuck”) spent every day in prison trying to be the best person, family member, friend and Christian he could be,” the statement read.

Nobile characterized Crawford as a respected, uplifting presence on death row. She said he worked inside the prison and advocated for other inmates.

The Associated Press made multiple attempts to contact Ray’s relatives but did not receive a response. Crawford also did not return requests for comment.

The lethal injection was the third in two days in the U.S. after executions Tuesday in Florida and Missouri. A total of 38 men have died by court-ordered execution so far this year.

There are six more executions scheduled to take place in 2025, the next being that of Richard Djerf, who was convicted of killing four members of a family in Arizona over 30 years ago.

This story has been updated to correct the name of the organization that represented Crawford to the Mississippi Office of Capital Post-Conviction Counsel, not the Mississippi Office of Capital Post-Conviction Relief.

FILE - This Aug. 3, 2017, photo provided by the Mississippi Department of Corrections shows Mississippi death row inmate Charles Ray Crawford. (Mississippi Department of Corrections via AP, file)

FILE - This Aug. 3, 2017, photo provided by the Mississippi Department of Corrections shows Mississippi death row inmate Charles Ray Crawford. (Mississippi Department of Corrections via AP, file)

維也納--(BUSINESS WIRE)--十二月 8, 2025--

(美國商業資訊)-- AOP Health持續推進其在骨髓增生性腫瘤(一類特殊且罕見的血液腫瘤)領域的臨床研發計畫。這家專注於罕見疾病治療的公司,於2025年在美國佛羅里達州奧蘭多舉行的第67 屆美國血液學會(American Society of Hematology, ASH)年會上,發布了兩項科學研究成果,將為治療策略帶來新的見解。

本新聞稿包含多媒體資訊。完整新聞稿請見此: https://www.businesswire.com/news/home/20251207103807/zh-HK/

ROP-ET與BESREMI PASS

其中一項臨床研究ROP-ET,探討Ropeginterferon alfa-2b在 原發性血小板增多症 (ET)患者中的使用情況。ET是一種由於體內產生的血小板過多而引發的疾病。此試驗為一項前瞻性、多中心、單組第III期臨床研究,評估Ropeginterferon alfa-2b在無法接受現有細胞減量治療 1 的ET患者中的安全性與療效。

另一項研究為BESREMI-PASS研究,旨在觀察該藥物在 原發性紅血球增多症 (PV)患者日常臨床治療中的效果。PV是一種罕見的血液幹細胞癌症,起源於骨髓造血幹細胞,會導致紅血球、白血球及血小板長期異常增多。

致力於滿足尚未被滿足的醫療需求

上述兩項研究,皆為Ropeginterferon α-2b在協助慢性血癌患者治療方面提供了新的見解。

AOP Health執行長Martin Steinhart總結道: 「AOP Health創立的初衷,正是為了回應罕見疾病領域中尚未被滿足的患者需求。我們對研發的持續投入,正體現了這項承諾,並帶來了新的研究成果。我們很榮幸能在ASH年會上,與全球科學界分享這些發現。」

關於Ropeginterferon alfa-2b

Ropeginterferon alfa-2b為全球首個獲准用於治療真性紅血球增多症(MPN)的干擾素藥物。依據歐盟核准內容,該藥物可作為單一療法,用於治療未出現脾腫大症狀的成人真性紅血球增多症患者。

Ropeginterferon alfa-2b屬於長效單聚乙二醇化脯氨酸干擾素(ATC:L03AB15)。初始治療階段為每兩週給藥一次,待血液學指標穩定後,可延長至每四週給藥一次。藥品採用預充式注射筆設計,供患者進行皮下注射使用。

關於AOP Health

AOP Orphan Pharmaceuticals GmbH (「AOP Health」)為一家跨國企業集團,根植於奧地利,集團總部亦設於此。自1996年成立以來,AOP Health Group持續致力於開發創新治療方案,以回應尚未被滿足的醫療需求,重點聚焦於罕見疾病與重症醫學領域。作為整合式治療方案的國際先驅,AOP Health Group透過子公司、代表處及強大的合作夥伴網路,在全球多地開展業務。秉持「需求、科學、信任」的核心理念,AOP Health Group強調對科研的長期承諾,並重視與醫療專業人士及病友組織的合作,確保關鍵利害關係人的需求能貫穿於公司各項行動之中。(aop-health.com)

1 Kiladjian JJ、Marin FF、Al-Ali HK等。ROP-ET:一項評估Ropeginterferon α-2b在治療選擇有限之原發性血小板增多症患者中有效性與安全性的前瞻性第III期臨床試驗。《血液學年鑑》,2024年3月4日:1–2。

需求、科學、信任。(Needs. Science. Trust.)
AOP Orphan Pharmaceuticals GmbH
AOP Health Group成員

免責聲明:本公告之原文版本乃官方授權版本。譯文僅供方便瞭解之用,煩請參照原文,原文版本乃唯一具法律效力之版本。

請前往 businesswire.com 瀏覽源版本:https://www.businesswire.com/news/home/20251207103807/zh-HK/

CONTACT: 深入咨詢

DI Isolde Fally

Isolde.Fally@aop-health.com

+43-676-500 4048

KEYWORD: AUSTRIA EUROPE UNITED STATES NORTH AMERICA

INDUSTRY KEYWORD: SCIENCE BIOTECHNOLOGY RESEARCH PHARMACEUTICAL ONCOLOGY GENERAL HEALTH HEALTH CLINICAL TRIALS

SOURCE: AOP Health

Copyright Business Wire 2025.

PUB: 12/08/2025 12:14 AM/DISC: 12/08/2025 12:15 AM

http://www.businesswire.com/news/home/20251207103807/zh

AOP Health執行長Martin Steinhart博士;圖片來源:AOP Health/Studio Koekart

AOP Health執行長Martin Steinhart博士;圖片來源:AOP Health/Studio Koekart

Recommended Articles